Skip to main content

Table 1 Characteristics of SLE patients and controls subjects

From: High-sensitivity cardiac troponin T is a biomarker for atherosclerosis in systemic lupus erythematous patients: a cross-sectional controlled study

  SLE (n = 63) Controls (n = 18) p value
Age, years 39 (29–63) 41 (30–61) 0.357
Female gender, n (%) 52 (82.5) 14 (77.8) 0.646
Smoker current, n (%) 24 (38.1) 8 (44.4) 0.627
LDL cholesterol, g/L 0.90 (0.36–1.53) 1.22 (0.74–1.72) 0.001
Hypertension, n (%) 16 (25.4) 4 (22.2) 0.783
SBP, mm Hg 125 (100–166) 125 (108–184) 0.498
10-Year cardiovascular riska, % 1 (1–18) 1 (1–13) 0.416
Overweightb, n (%) 24 (38.1) 8 (44.4) 0.627
Waist circumference, cm 90 (74–150) 91 (74–117) 0.852
eGFRc, mL/min/1.73 m2 92 (54–127) 76 (60–99) 0.221
HbA1c, % 5.5 (4.4–6.7) 5.5 (4.6–6.5) 0.988
Antiplatelet treatment, n (%) 7 (11.1) 1 (5.6) 0.486
Statin, n (%) 15 (23.8) 2 (11.1) 0.139
ACE inhibitors, n (%) 16 (25.4) 3 (16.7) 0.440
ARBs, n (%) 5 (7.9) 0 0.217
Carotid plaqued, n (%) 23 (36.5) 2 (11.1) 0.039
  1. Results are shown as median (range) or number (percentage)
  2. Analysis was performed on 81 subjects
  3. a10-year cardiovascular risk was calculated using the Framingham equation
  4. bOverweight was defined as a body mass index >25 kg/m2
  5. cEstimated glomerular filtration rate (eGRF) was calculated with the Modification of Diet in Renal Disease (MDRD) equation
  6. dCarotid plaques were defined as an internal carotid wall thickness at the carotid bulb >1.5 mm
  7. ACE Angiotensin converting enzyme, ARB Angiotensin II receptor antagonist, HbA1c haemoglobin A1c, LDL low-density lipoprotein, SBP systolic blood pressure, SLE systemic lupus erythematosus
\